Total submissions: 6
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
Labcorp Genetics |
RCV000630364 | SCV000751320 | likely benign | Hereditary nonpolyposis colorectal neoplasms | 2023-10-12 | criteria provided, single submitter | clinical testing | |
Counsyl | RCV000662860 | SCV000785745 | uncertain significance | Lynch syndrome 1 | 2017-11-27 | criteria provided, single submitter | clinical testing | |
Ambry Genetics | RCV001014480 | SCV001175194 | likely benign | Hereditary cancer-predisposing syndrome | 2018-07-25 | criteria provided, single submitter | clinical testing | This alteration is classified as likely benign based on a combination of the following: seen in unaffected individuals, population frequency, intact protein function, lack of segregation with disease, co-occurrence, RNA analysis, in silico models, amino acid conservation, lack of disease association in case-control studies, and/or the mechanism of disease or impacted region is inconsistent with a known cause of pathogenicity. |
Color Diagnostics, |
RCV001014480 | SCV001344424 | likely benign | Hereditary cancer-predisposing syndrome | 2020-01-06 | criteria provided, single submitter | clinical testing | |
Myriad Genetics, |
RCV000662860 | SCV004018400 | benign | Lynch syndrome 1 | 2023-03-22 | criteria provided, single submitter | clinical testing | This variant is considered benign. This variant is a silent/synonymous amino acid change and it is not expected to impact splicing. |
All of Us Research Program, |
RCV003997158 | SCV004825669 | likely benign | Lynch syndrome | 2023-11-20 | criteria provided, single submitter | clinical testing |